Skip to main content
logo
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.24
+0.05 (0.54%)
At close: Aug 10, 2026, 4:00 PM EDT
9.20
-0.04 (-0.43%)
After-hours: Aug 10, 2026, 4:56 PM EDT

Ocular Therapeutix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
52.0551.9563.7258.4451.4943.52
Revenue Growth
-8.14%-18.47%9.03%13.49%18.32%150.08%
Gross Profit
45.3545.3858.153.1646.9539.12
Operating Income
-313.91-270.02-171.78-82.38-78.65-78.04
Net Income
-301.45-265.94-193.51-80.74-71.04-6.55
Earnings Per Share
-1.42-1.42-1.22-1.02-0.97-0.98
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
000195.81102.3164.16
Total Debt
79.3876.9775.7883.3964.2858.98
Net Cash (Debt)
-79.38-76.97-75.78112.4238.02105.18
Net Cash Growth
---195.70%-63.86%-37.99%
Net Cash Per Share
-0.37-0.41-0.481.310.461.28

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-238.24-204.88-134.68-70.23-59.6-65.55
Capital Expenditures
-16.86-12.01-1.29-6.09-3.72-1.19
Free Cash Flow
-255.1-216.89-135.97-76.32-63.32-66.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
87.11%87.35%91.17%90.96%91.18%89.88%
Operating Margin
-603.04%-519.75%-269.57%-140.96%-152.74%-179.31%
Pretax Margin
-579.10%-511.90%-303.67%-138.14%-137.95%-15.06%
Profit Margin
-579.10%-511.90%-303.67%-138.15%-137.95%-15.06%
FCF Margin
-490.07%-417.50%-213.37%-130.59%-122.96%-153.36%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
38.9650.4621.148.774.2112.29